Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) has 324 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 37,458 | 0.43% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 3,746 | 0.06% | $0.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 0 | 503,316 | 28.57% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -230,520 | -67.80% | $0.00 |
| ARMISTICE CAPITAL, LLC | 31 Dec, 2025 | 0 | -72,000 | -2.54% | $0.00 |
| Sofinnova Investments, Inc. | 31 Dec, 2025 | 0 | 176,029 | 46.68% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 1,506 | 809.68% | $0.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Dec, 2025 | 0 | -289,600 | -9.65% | $0.00 |
| Pictet Asset Management Holding SA | 31 Dec, 2025 | 0 | -25,526 | -5.02% | $0.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 0 | 2,293,773 | 662.38% | $0.00 |
| Krensavage Asset Management, LLC | 31 Dec, 2025 | 0 | -49,980 | -13.75% | $0.00 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 31 Dec, 2025 | 0 | 2,307,639 | 0.00% | $0.00 |
| Qube Research & Technologies Ltd | 31 Dec, 2025 | 0 | 187,715 | 151.23% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 31,668 | 1.45% | $0.00 |
| Aberdeen Group plc | 31 Dec, 2025 | 0 | 271,574 | 0.00% | $0.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 0 | -8,100 | -0.47% | $0.00 |
| Catalio Capital Management, LP | 31 Dec, 2025 | 0 | -29,625 | -10.32% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 62,875 | 4.46% | $0.00 |
| Aristotle Capital Boston, LLC | 31 Dec, 2025 | 0 | -70,770 | -23.18% | $0.00 |
| LOOMIS SAYLES & CO L P | 31 Dec, 2025 | 0 | 162,905 | 12.67% | $0.00 |